DMII · Nasdaq, Nasdaq, Nasdaq · CIK 0002040475

Drugs Made In America Acquisition II Corp.

Drugs Made In America Acquisition II Corp.’s most recent SEC filing in our snapshot is a Form 10-Q filed on Aug 14, 2026. Its EDGAR record lists 0 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
—
Net income, FY2025
$4.2M
Form 4 filings on record, past 12 months
0

Company overview

Legal name (as filed)
Drugs Made In America Acquisition II Corp.
Tickers
DMII, DMIIR, DMIIU
SEC Central Index Key (CIK)
0002040475
Industry (SIC)
Blank Checks (code 6770)
Business address
NEW YORK, NY
State or country of incorporation
—
Fiscal year ends
December 31
SEC filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Position in SEC ticker list
#2739 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Drugs Made In America Acquisition II Corp.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
n/aFY2025
Net income
$4.2MFY2025
DMII annual results
ItemFY2025
ended Dec 31, 2025
Revenue—
Net income$4.2M
Diluted EPS—
Total assets$505.0M
Cash and equivalents$223

XBRL tags used: netIncome = NetIncomeLoss; assets = Assets; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

DMII latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Apr 15, 202610-KANNUAL REPORT· period Dec 31, 2025Document · Index
Aug 14, 202610-QQUARTERLY REPORT· period Jun 30, 2026Document · Index
Apr 28, 20268-KMaterial agreement· period Apr 22, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Drugs Made In America Acquisition II Corp., by form type:

8-K ×83 ×64 ×6CORRESP ×410-Q ×3S-1/A ×310-K ×1NT 10-K ×1NT 10-Q ×1SCHEDULE 13D ×1424B4 ×1EFFECT ×1CERT ×18-A12B ×1UPLOAD ×1S-1 ×1
DMII recent filings
FiledFormWhat it isOriginal
Aug 14, 202610-QQUARTERLY REPORT· period Jun 30, 2026Document · Index
May 14, 202610-QQUARTERLY REPORT· period Mar 31, 2026Document · Index
Apr 28, 20268-KMaterial agreement· period Apr 22, 2026Document · Index
Apr 15, 202610-KANNUAL REPORT· period Dec 31, 2025Document · Index
Apr 3, 20268-KMaterial agreement; New financial obligation· period Mar 24, 2026Document · Index
Apr 1, 2026NT 10-KNOTIFICATION OF LATE FILING· period Dec 31, 2025Document · Index
Mar 17, 20268-KMaterial agreement; New financial obligation; Other events· period Mar 11, 2026Document · Index
Mar 6, 20268-KOther events· period Mar 6, 2026Document · Index
Mar 6, 20268-KDirector or officer change· period Feb 28, 2026Document · Index
Nov 18, 202510-QQUARTERLY REPORT· period Sep 30, 2025Document · Index
Nov 18, 20258-KDirector or officer change· period Oct 8, 2025Document · Index
Nov 17, 2025NT 10-QNOTIFICATION OF LATE FILING· period Sep 30, 2025Document · Index
Oct 17, 20254Statement of changes in beneficial ownership (insider trade)· period Sep 26, 2025Document · Index
Oct 2, 20258-KOther events· period Sep 26, 2025Document · Index
Oct 2, 20254Statement of changes in beneficial ownership (insider trade)· period Sep 26, 2025Document · Index
Oct 2, 2025SCHEDULE 13DActive beneficial ownership report (over 5%)Document · Index
Oct 1, 20254Statement of changes in beneficial ownership (insider trade)· period Sep 26, 2025Document · Index
Oct 1, 20254Statement of changes in beneficial ownership (insider trade)· period Sep 26, 2025Document · Index
Oct 1, 20254Statement of changes in beneficial ownership (insider trade)· period Sep 26, 2025Document · Index
Oct 1, 20254Statement of changes in beneficial ownership (insider trade)· period Sep 26, 2025Document · Index
Sep 29, 20258-KMaterial agreement; Unregistered equity sale; Director or officer change; Charter, bylaws or fiscal year change; Other events· period Sep 24, 2025Document · Index
Sep 25, 20253Initial statement of beneficial ownership· period Sep 24, 2025Document · Index
Sep 25, 2025424B4PROSPECTUS SUPPLEMENTDocument · Index
Sep 24, 2025EFFECTEFFECTDocument · Index
Sep 24, 2025CERTCERTDocument · Index
Sep 24, 20253Initial statement of beneficial ownership· period Sep 24, 2025Document · Index
Sep 24, 20253Initial statement of beneficial ownership· period Sep 24, 2025Document · Index
Sep 24, 20253Initial statement of beneficial ownership· period Sep 24, 2025Document · Index
Sep 24, 20253Initial statement of beneficial ownership· period Sep 24, 2025Document · Index
Sep 24, 20253Initial statement of beneficial ownership· period Sep 24, 2025Document · Index
Sep 24, 20258-A12BFOR REGISTRATION OF CERTAIN CLASSESDocument · Index
Sep 22, 2025CORRESPCORRESPDocument · Index
Sep 22, 2025CORRESPCORRESPDocument · Index
Sep 16, 2025CORRESPCORRESPDocument · Index
Sep 16, 2025S-1/AREGISTRATION STATEMENTDocument · Index
Sep 15, 2025S-1/AREGISTRATION STATEMENTDocument · Index
Sep 15, 2025UPLOADUPLOADDocument · Index
Sep 5, 2025S-1/AREGISTRATION STATEMENTDocument · Index
Jul 21, 2025S-1REGISTRATION STATEMENTDocument · Index
Jul 18, 2025CORRESPCORRESPDocument · Index

Insider filing activity

0 Form 4 filings appear in Drugs Made In America Acquisition II Corp.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Blank Checks

All 13 companies in Blank Checks· Companies headquartered in New York

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0002040475 and XBRL company facts. Drugs Made In America Acquisition II Corp. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.